Research From the 2012 Genitourinary Cancers Symposium Highlights New Treatments, Compares Existing Therapies for ...

Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer were released today, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Calif.

Generex Announces Patent Award for its Core Vaccine Technologies in Japan

WORCESTER, Mass. and TORONTO, Feb. 1, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) announced today that its wholly owned subsidiary, Antigen Express, Inc., has been awarded a ...

Cancer Deaths - Enormous Drop Over Last 20 Years, USA

Over the last twenty years, more than one million deaths from cancer have been avoided, researchers reported in CA: A Cancer Journal for Clinicians. Death rates for the most common cancers, including colon, breast, prostate and lung cancers have been dropping steadily year after year. However, some rarer cancers, such has kidney, thyroid, liver and pancreas cancers have seen death rates and ...

The War on Cancer Phobia | The Crux

David Ropeik is an international consultant in risk perception and risk communication, and an Instructor in the Environmental Management Program at the Harvard University Extension School. He is the author of How Risky Is It, Really? Why Our Fears Don’t Always Match the Facts and principal co-author of RISK A Practical Guide for Deciding What’s Really Safe and What’s Really Dangerous in the ...

Is Oral Sex to Blame for the Surge in Cancer of the Mouth and Throat?

It's the typical culprit, but other factors, including immune changes, nicotine damage, and even a genetic disposition, could play a part.